This meeting will highlight recent advances in modeling cancer using mouse models, cell lines, organoids, PDX models, and computational models, focusing on their impact for advancing our understanding of cancer biology, prevention and treatment, and drug response and resistance.
This EACR-AACR-ASPIC conference on Tumor Microenvironment (TME) will bring together thought leaders spanning the breadth of TME, immune-oncology, computational biology and biomedical technology disciplines to discuss novel approaches to identify critical mechanisms regulating the crosstalk in these tumor ecosystems.
The aim of this AACR Special Conference is to move away from the simplistic view of cancer evolution as a merely genetic phenomenon and to discuss instead how microenvironmental, immune cell, genetic and epigenetic heterogeneity interact and evolve and how this influences cancer progression and therapy success or failure.
This AACR Special Conference will cover the current findings on the basic biology underlying prostate cancer and how these may be translated to the clinic.
The Cancer, Autoimmunity, and Immunology Conference was created to delve into understanding the biology of immune-related adverse events that have occurred in cancer patients treated with immunotherapies.
This collaboration will bring together basic scientists and clinical researchers from the United States, Japan, and around the world to share the latest and most exciting developments in pancreatic cancer research.
This must-attend program will consist of a series of bench-to-bedside debates on critical questions and unmet needs in the lymphoma field, followed by extended, interactive panel discussions.